Variant report
Variant | esv3366837 |
---|---|
Chromosome Location | chr2:205967157-205969155 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:7)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:7 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr2:205967584-205967615 | ProgFib | skin: | n/a | n/a |
2 | CTCF | chr2:205967692-205967760 | Medullo | brain: | n/a | n/a |
3 | EP300 | chr2:205968473-205968768 | SK-N-SH_RA | brain: | n/a | n/a |
4 | EP300 | chr2:205968187-205969061 | SK-N-SH | brain: | n/a | chr2:205968833-205968847 |
5 | EP300 | chr2:205968485-205968769 | SK-N-SH_RA | brain: | n/a | n/a |
6 | TCF12 | chr2:205968409-205968980 | SK-N-SH | brain: | n/a | n/a |
7 | TCF12 | chr2:205968393-205968910 | SK-N-SH | brain: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:205966282..205968302-chr2:205970008..205973001,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
PARD3B | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs138653377 | chr2:205967174-205967175 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs201121440 | chr2:205967178-205967179 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs542119731 | chr2:205967189-205967190 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs560469911 | chr2:205967203-205967204 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs527444676 | chr2:205967256-205967257 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs13429972 | chr2:205967315-205967316 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs564196985 | chr2:205967324-205967325 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs566508039 | chr2:205967331-205967332 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs549726250 | chr2:205967334-205967335 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs567933091 | chr2:205967417-205967418 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs535096432 | chr2:205967432-205967433 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs370291837 | chr2:205967438-205967439 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs13430090 | chr2:205967440-205967441 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs182575961 | chr2:205967443-205967444 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs534123052 | chr2:205967459-205967460 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs558927028 | chr2:205967510-205967511 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs570909407 | chr2:205967516-205967517 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs537983816 | chr2:205967517-205967518 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs149554708 | chr2:205967547-205967548 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs574853032 | chr2:205967548-205967549 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs10196569 | chr2:205967559-205967560 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs554064445 | chr2:205967604-205967605 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs572408618 | chr2:205967610-205967611 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs371619342 | chr2:205967616-205967617 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs564152993 | chr2:205967658-205967659 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs531553134 | chr2:205967684-205967685 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs543114976 | chr2:205967715-205967716 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs187574815 | chr2:205967723-205967724 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs531624389 | chr2:205967724-205967725 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs528811591 | chr2:205967727-205967728 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs71427767 | chr2:205967770-205967771 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs199568925 | chr2:205967806-205967807 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs377422159 | chr2:205967807-205967808 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs10211581 | chr2:205967813-205967814 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs28666710 | chr2:205967814-205967815 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs28521945 | chr2:205967815-205967816 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs13036099 | chr2:205967820-205967821 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs13432993 | chr2:205967821-205967822 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs28653604 | chr2:205967822-205967823 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs13036104 | chr2:205967826-205967827 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs566815406 | chr2:205967828-205967829 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs71032439 | chr2:205967853-205967854 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs71408999 | chr2:205967880-205967881 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs201568771 | chr2:205967886-205967887 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs368648915 | chr2:205967888-205967889 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs371850936 | chr2:205967891-205967892 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs150083874 | chr2:205967901-205967902 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs111692029 | chr2:205967906-205967907 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs138398005 | chr2:205967950-205967951 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs370868931 | chr2:205967955-205967956 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioblastoma | 21080181 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Papillary thyroid carcinoma | 22161024 | CNVD |
Cervical cancer | 21062161 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Prostate cancer | 16573809 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Cancer | 20164920 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:205953400-205978600 | Weak transcription | Fetal Lung | lung |
2 | chr2:205953400-206007200 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
3 | chr2:205959600-205971600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
4 | chr2:205963800-205990200 | Weak transcription | Ovary | ovary |
5 | chr2:205968200-205986200 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
6 | chr2:205968800-205972200 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
7 | chr2:205968800-205978200 | Weak transcription | HSMM | muscle |
8 | chr2:205968800-205990200 | Weak transcription | Adipose Nuclei | Adipose |